As part of EASL’s ground-breaking Digital ILC 2020, the EASL Takeaways look back on key topics from the congress, with leading experts discussing the most impactful science and putting it into perspective.
This episode sees 3 internationally renowned experts in viral hepatitis – Professor Ulrich Spengler, Professor Geoffrey Dusheiko and Dr. Tobias Böttler – recap the key developments revealed at the congress. The panel discussed different studies ranging from the Stop-NUC trial and the potential for durable immune control and functional cure in HbeAg-negatuive patients, as well as new data on novel therapies and new experimental observations.
The EASL Takeaways are hosted on EASL Campus. To access them, please log in with your credentials. If you do not have an EASL Campus account yet, please create one here, free of charge. |
